Development of an HPLC Method for Determination of Related Impurities in Prilocaine Substance

被引:4
|
作者
Sroka-Markovic, Janina [2 ]
Johansson, Linda [2 ]
Andersson, Magnus B. O. [2 ]
Granelli, Ingrid [1 ]
机构
[1] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden
[2] AstraZeneca, Analyt Dev, S-15185 Sodertalje, Sweden
关键词
LC; Prilocaine impurities; Local anaesthetics; Prilocaine; Hypercarb; Porous graphitized carbon; POROUS GRAPHITIC CARBON; PERFORMANCE LIQUID-CHROMATOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; STATIONARY PHASES; COLUMNS; CLASSIFICATION; SEPARATION; RETENTION; ISOMERS; ION;
D O I
10.1007/s10337-012-2212-x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Development of a reversed phase high performance liquid chromatographic method for determination of six related impurities in prilocaine substance is reported. The test of related impurities in European Pharmacopoeia (Ph. Eur.) cannot meet the demands with the chromatographic parameters given, therefore different types of chromatographic systems and eight columns have been evaluated in the present study. A new method with a Hypercarb column was developed and validated. This method fulfils the demands in the Ph. Eur., and the validation shows that the method is selective, reproducible, linear, accurate and robust with sufficient limits of detection (0.001-0.004% of 2.5 mg prilocaine mL(-1)) and quantification (0.002-0.009% of 2.5 mg prilocaine mL(-1)).
引用
收藏
页码:329 / 336
页数:8
相关论文
共 50 条
  • [41] DEVELOPMENT OF METHODS FOR DETERMINATION OF SPECIFIC IMPURITIES IN THE GLUTATIONION RESTORED SUBSTANCE
    Alexeeva, K. A.
    Pisarev, D., I
    Malyutina, A. Yu
    Boyko, N. N.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2018, 6 (06): : 535 - 547
  • [42] Quality by design (QbD) based development and validation of an HPLC method for amiodarone hydrochloride and its impurities in the drug substance
    Karmarkar, S.
    Yang, X.
    Garber, R.
    Szajkovics, A.
    Koberda, M.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 100 : 167 - 174
  • [43] Validation of an HPLC method for determination of aripiprazole and its impurities in pharmaceuticals
    Filijovic, N. Djordjevic
    Pavlovic, A.
    Nikolic, K.
    Agbaba, D.
    ACTA CHROMATOGRAPHICA, 2014, 26 (01) : 13 - 28
  • [44] Validated Reverse Phase HPLC Method for the Determination of Impurities in Etoricoxib
    Venugopal, S.
    Tripathi, U. M.
    Devanna, N.
    E-JOURNAL OF CHEMISTRY, 2011, 8 : S119 - S126
  • [45] HPLC method for simultaneous determination of impurities and degradation products in Cardiazol
    Drapak, Iryna
    Zimenkovsky, Borys
    Ivanauskas, Liudas
    Bezruk, Ivan
    Perekhoda, Lina
    Muzychenko, Volodymir
    Logoyda, Liliya
    Demchuk, Inna
    PHARMACIA, 2020, 67 (01) : 29 - 37
  • [46] HPLC Method Development and Validation for the Quantification of Related Impurities in Testosterone Cypionate Active Pharmaceutical Ingredient
    Bharti, Amber
    Kumbhare, Ravindra Motiram
    Jeyaseelan, Christine
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2022, 56 (01) : 240 - 246
  • [47] HPLC method for simultaneous determination of impurities and degradation products in zonisamide
    Vijayakumar, E. K. S.
    Dhore, D. M.
    Kumar, M.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 71 (05) : 521 - 526
  • [48] A new stability-indicating HPLC-UV method for determination of amlodipine besylate and its impurities in drug substance
    Jeelani, Salika
    Kouznetsova, Natalia
    HELIYON, 2023, 9 (09)
  • [49] A Validated RP-HPLC Method for Quantitative Determination of Related Impurities of Cholic Acid Bulk Drugs
    Sheng, Zhaojun
    Ye, Ruhan
    Ge, Siyuan
    Wang, Chenggang
    Xu, Xuetao
    Zhang, Guangwen
    Luo, Ping
    ACTA CHROMATOGRAPHICA, 2018, 30 (02) : 114 - 118
  • [50] A new RP-HPLC method for separation and determination of process related impurities in Pioglitazone Hydrochloride API
    Srinivasulu, D.
    Sastry, B. S.
    Prakash, G. O.
    Archana, D. N. S. S.
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 2014, 73 (09): : 618 - 621